Mirum Pharmaceuticals Inc
MIRM
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.94B
Close$
$27.50
72.7% downside
Current Fair Value
72.7% downsideOvervalued by 72.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.94 Billion |
|---|---|
| Enterprise Value | $6.37 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 0.51 |
| Outstanding Shares | 63,374,183 |
Return
| Return on Equity | 8253.76% |
|---|---|
| Return on Assets | -82.32% |
| Return on Invested Capital | -98.09% |
Valuation & Multiples
| P/E Ratio | -6.69 |
|---|---|
| PEG | -0.64 |
| Price to Sales | 14.38 |
| Price to Book Ratio | -100.63 |
| Enterprise Value to Revenue | 13.91 |
| Enterprise Value to EBIT | -7.9 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | -72.97 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.74
Average shareholder expectationRevenue Estimate
$166.33 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.53
Average shareholder expectationRevenue Estimate
$178.06 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4855▲ 41.07% |
|---|---|
| Total Calls | 100,100▼ 53.46% |
| Total Puts | 48,600▲ 201.86% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 131.66%▼ 4.30% |
|---|---|
| Total Invested | $8.46B▲ 34.43% |
| Investors Holding | 337▲ 19.00% |
ESG Score
No data